Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001787306-24-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-05 | 2024-08-01 | ARQT | Welgus Howard G. | Dir | S - Sale+OE | $9.87 | -10.0K | 177.0K | -5% | -$98.7K |
| D | 2024-08-05 | 2024-08-01 | ARQT | Welgus Howard G. | Dir | M - OptEx | $1.68 | +6,614 | 187.0K | +4% | +$11.1K |
| D | 2024-08-05 | 2024-08-01 | ARQT | Welgus Howard G. | Dir | M - OptEx | $0.00 | -6,614 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 6,614 | $9.87 | 180,339 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.76 to $10.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-08-01 | M | A | 6,614 | $1.68 | 186,953 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-01 | S | D | 3,386 | $9.87 | 176,953 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.76 to $10.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (right to buy) | 2024-08-01 | M | D | 6,614 | $0.00 | 0 | D | $1.68 · — to 2029-03-13 | 6,614 Common Stock | (F4) This option is fully vested. |